These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2475079)

  • 1. Plasma alpha 2-antiplasmin activity. Role in the evaluation and management of fibrinolytic states and other bleeding disorders.
    Williams EC
    Arch Intern Med; 1989 Aug; 149(8):1769-72. PubMed ID: 2475079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency.
    Schwartz BS; Williams EC; Conlan MG; Mosher DF
    Ann Intern Med; 1986 Dec; 105(6):873-7. PubMed ID: 3465267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the fibrinolytic state by measuring stable cross-linked fibrin degradation products in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
    Okajima K; Koga S; Okabe H; Inoue M; Takatsuki K
    Acta Haematol; 1989; 81(1):15-8. PubMed ID: 2494830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukaemia.
    Avvisati G; ten Cate JW; Sturk A; Lamping R; Petti MG; Mandelli F
    Br J Haematol; 1988 Sep; 70(1):43-8. PubMed ID: 2460126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravascular coagulation in acute promyelocytic leukemia: analysis of coagulation and fibrinolysis parameters].
    Chuecas F; Loredo E; Muñoz B; Alfaro J; Grebe G; Lira P
    Rev Med Chil; 1991 Sep; 119(9):984-9. PubMed ID: 1845106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients.
    Wassenaar T; Black J; Kahl B; Schwartz B; Longo W; Mosher D; Williams E
    Hematol Oncol; 2008 Dec; 26(4):241-6. PubMed ID: 18613223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bleeding disorder due to deficiency of alpha 2-antiplasmin.
    Kettle P; Mayne EE
    J Clin Pathol; 1985 Apr; 38(4):428-9. PubMed ID: 3988955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolysis and acquired alpha-2 plasmin inhibitor deficiency in amyloidosis.
    Meyer K; Williams EC
    Am J Med; 1985 Sep; 79(3):394-6. PubMed ID: 4036990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiplasmin drugs and factor XIII concentrates in the treatment of a patient with acute promyelocytic leukemia (M3)].
    Ryo R; Sugano W; Yoshida A; Adachi M; Yasunaga M; Yoneda N; Saigo K; Kondo S; Yamaguchi N; Nobusawa A
    Gan No Rinsho; 1989 Oct; 35(12):1479-82. PubMed ID: 2810783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bleeding disorder due to deficiency of alpha 2-antiplasmin.
    Miles LA; Plow EF; Donnelly KJ; Hougie C; Griffin JH
    Blood; 1982 Jun; 59(6):1246-51. PubMed ID: 7082827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha 2-antiplasmin.
    Kluft C; Vellenga E; Brommer EJ; Wijngaards G
    Blood; 1982 Jun; 59(6):1169-80. PubMed ID: 6177359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative reexploration for cardiac postoperative bleeding: can it be therapeutic?
    Pelletier MP; Solymoss S; Lee A; Chiu RC
    Ann Thorac Surg; 1998 Apr; 65(4):999-1002. PubMed ID: 9564917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmin-alpha 2-antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysis.
    Booth NA; Bennett B
    Br J Haematol; 1984 Apr; 56(4):545-56. PubMed ID: 6201189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 2-plasmin inhibitor and its deficiency states.
    Saito H
    J Lab Clin Med; 1988 Dec; 112(6):671-8. PubMed ID: 3057093
    [No Abstract]   [Full Text] [Related]  

  • 15. [Atypical defibrination syndromes and acute leukemias with a t(9,22) translocation, apropos of 2 cases].
    Meddeb B; Guermazi S; Hafsia R; Ben Abid H; Gouider E; Ben Lakhal R; Bel Haj Ali Z; Ben Othman T; Jeddi R; Dellagi K; Hafsia A
    Pathol Biol (Paris); 2001 Apr; 49(3):232-6. PubMed ID: 11367558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis and fibrinogenolysis in disseminated intravascular coagulation.
    Takahashi H; Tatewaki W; Wada K; Niwano H; Shibata A
    Thromb Haemost; 1990 Jun; 63(3):340-4. PubMed ID: 2402738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamics of blood coagulation and fibrinolysis and laboratory findings in disseminated intravascular coagulation].
    Madoiwa S
    Rinsho Ketsueki; 2010 Jan; 51(1):20-8. PubMed ID: 20134136
    [No Abstract]   [Full Text] [Related]  

  • 18. Coagulopathy in hemorrhagic fever with renal syndrome (Korean hemorrhagic fever).
    Lee M; Kim BK; Kim S; Park S; Han JS; Kim ST; Lee JS
    Rev Infect Dis; 1989; 11 Suppl 4():S877-83. PubMed ID: 2568677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concepts of clot lysis.
    Francis CW; Marder VJ
    Annu Rev Med; 1986; 37():187-204. PubMed ID: 2939790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL; Mathew P
    Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.